2018-11-19 | Ascelia Pharma receives positive feedback from FDA on design of the pivotal Phase 3 study with Mangoral® PDF Report Presentation Webcast
2018-11-13 | Encouraging results from clinical Phase I study of Oncoral presented in a new publication PDF Report Presentation Webcast
2018-10-23 | Oncoral demonstrates encouraging results in clinical phase I PDF Report Presentation Webcast
Regulatory 2018-09-14 | Carl Bjartmar appointed as new Chief Medical Officer for Ascelia Pharma PDF Report Presentation Webcast
2018-09-10 | Oncoral phase 1 results to be presented at ESMO congress in Munich PDF Report Presentation Webcast
Regulatory 2018-05-16 | Ascelia Pharma has raised SEK 60 million to finalize phase III preparations for Mangoral® PDF Report Presentation Webcast
